Search

Search Constraints

You searched for: Author/Creator Haydon, Andrew

Search Results

2. 194 A multicenter characterization of chronic toxicities following adjuvant anti-PD-1 therapy for high risk resected melanoma. (10th December 2020)

3. 194 A multicenter characterization of chronic toxicities following adjuvant anti-PD-1 therapy for high risk resected melanoma. (9th November 2020)

4. 602Prevalence of cancer history and association with risk factors in a healthy older population. (2nd September 2021)

5. 783Lifetime alcohol intake and stomach cancer risk: a pooled analysis of two prospective cohort studies. (2nd September 2021)

6. 799 Durable responses and immune activation with intratumoral electroporation of pIL-12 plus pembrolizumab in actively progressing anti-PD-1 refractory advanced melanoma: KEYNOTE 695 interim data. (10th December 2020)

7. A Randomized Controlled Trial of a Nurse-Led Supportive Care Package (SurvivorCare) for Survivors of Colorectal Cancer. (15th June 2016)

8. A Randomized Controlled Trial of a Nurse‐Led Supportive Care Package (SurvivorCare) for Survivors of Colorectal Cancer. (15th June 2016)

9. Adapting pharmacy experiential education during COVID-19: Innovating remote preceptor resources, tools, and patient care delivery beyond virtual meetings. (5th May 2021)

10. Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915). Issue 3 (26th September 2022)